ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 268965 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 268965; 2) Community: the network communities that were significantly associated with the response to NSC 268965; 3) Molecule: the relationships between components within communities and NSC 268965; 4) MDR: the compounds that were significantly associated with the NSC 268965.

NSC Compound Enrichment Correlation
NSC 736591 Null 0.0438391811600412 -0.1695702
NSC 749160 Null 0.0438391811600412 0.069646571
NSC 314622 Indenoisoquinoline derivative 0.045446901295916 0.59491005
NSC 330500 Macbecin II 0.045446901295916 0.0030993857
NSC 351907 MASTOPARAN 0.045446901295916 0.021384427
NSC 356885 Leucinostatin A (9CI) 0.045446901295916 -0.075890922
NSC 39202 Cyclohexanone, 2,6-bis(piperidinomethyl)- 0.045446901295916 0.072677874
NSC 58906 9H-Purine, 6-[(o-chlorobenzyl)thio]-9-(2-chloroethyl)- (8CI) 0.045446901295916 0.22183564
NSC 609699 Topotecan hydrochloride 0.045446901295916 0.54722751
NSC 619859 1H-3-Benzazepin-2-one, 2,3,4,5-tetrahydro-7,8-dimethoxy- 3-[(2,3-dimethoxyphenyl)methyl]-1-methylthio- 0.045446901295916 -0.073046089
Total:50  Current:39    [First] [Prev] [Next] [Last]